Back to Authors

Walsh, Thomas J.

https://orcid.org/0000-0002-7078-9778

Mayo Clinic

NewYork–Presbyterian Hospital

Citations 1

Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes
Sfeir, Maroun M. , Borczuk, Alain , Soave, Rosemary, Jenkins, Stephen G., Walsh, Thomas J. , Small, Catherine B. , Schuetz, Audrey, Schuetz, Audrey N. , Besien, Koen van

Journal of Clinical Pathology | January 24, 2018 | Volume: 71 | Issue: 7 | Pages: 626-630

10.1136/jclinpath-2017-204777 Get It

Introduction Mycobacterial spindle cell pseudotumour (MSP) is a rare disease characterised by tumour-like local proliferation of spindle-shaped histiocytes containing acid-fast positive mycobacteria. The aim of this literature review is to describe the clinical parameters and treatment outcomes of patients with MSP. Methods A literature search was conducted using the search terms related to mycobacteria and spindle cell tumours. A previously unreported stem cell transplant recipient from our institution diagnosed with MSP was also included. Demographics, comorbidities, site of infection, treatment and clinical outcomes were analysed. Results Fifty-one patients were analysed. Twenty-six (51%) had HIV infection. Mycobacterium avium complex was the most frequent organism isolated in 24 (47.1%) followed by Mycobacterium tuberculosis complex in eight (16%) cases. Lymph nodes were the most common site of infection (45.1%). Twenty (39.2%) patients received antimycobacterial agents, 12 (23.5%) underwent surgical resection and six (11.8%) received antimycobacterial agents plus surgery. Treatment was successful in 24 (47.1%) patients and failed in 15 (29.4%); 13 of these 15 patients died. Antimycobacterial therapy was significantly associated with successful outcome compared with surgical resection or no treatment (P<0.001). Conclusion MSP is a rare condition associated primarily with immunodeficiencies. Antimycobacterial therapy is significantly associated with successful outcome.